| Clinical parameters (total subjects: 79) |
PCa (41) |
BPH (38) |
| Median Age |
65 (54-75) |
66 (48-74) |
| Median PSA (ng/mL) |
7.32 (3.54-50) |
7.24 (1.38-21.22) |
| Clinical Gleason Score |
6 (3+3) |
32 |
- |
| 7 (3+4) |
6 |
| 7 (4+3) |
1 |
| 8 (4+4) |
1 |
| 9 (5+4) |
1 |
| Clinical staging |
cT1c |
23 |
| cT2a |
13 |
| cT2c |
3 |
| cT3a |
2 |
| Pathological Gleason Score |
6 (3+3) |
29 |
- |
| 7 (3+4) |
9 |
| 7 (4+3) |
1 |
| 8 (4+4) |
1 |
| 10 (5+5) |
1 |
| Pathological Staging |
pT2a |
4 |
| pT2c |
28 |
| pT3a |
6 |
| pT3b |
3 |
| Positive Surgical Margin |
15% |
- |
|
